Company: WHWK
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001628280-25-020311
Chunk: 54

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 54
---
 of more than 5% of our common stock.

(5) Dr. Zhao is a member of our board of directors and is the sole manager of WZCUBE LLC.

<div align='center'>33</div>

(6) Mr. Ball has been our Chief Technical Operations Officer since March 2024 and served as our Chief Quality Officer and SVP Manufacturing Operations from July 2022 to March 2024.

#### Stockholder Support Agreements
In connection with the execution of the Subscription Agreement, KAKEN and the Company entered into support agreements with each of the directors and executive officers of the Company, certain of their affiliates, and one other significant stockholder of Company (the "Support Agreements"), who collectively beneficially owned or controlled an aggregate of approximately 39.3% of the outstanding shares of the Company’s common stock as of the record date of the Special Meeting of Stockholders to approve the Divestiture and PIPE Financing (the "Special Meeting"). T he Support Agreements provided that, among other things, each of the stockholders agreed to vote or cause to be voted all of the shares of the Company's common stock beneficially owned by such stockholder as of the record date of the Special Meeting in favor of the Subscription Agreement, the Divestiture and the other transactions contemplated by the Subscription Agreement, as well as certain other transactions, at the Special Meeting.

Indemnification Agreements and Directors’ and Officers’ Liability Insurance

We have entered into indemnification agreements with each of our directors and executive officers. These agreements, among other things, require us to indemnify each director and executive officer to the fullest extent permitted by Delaware law, including indemnification of expenses such as attorneys’ fees, judgments, fines and settlement amounts incurred by the director or executive officer in any action or proceeding, including any action or proceeding by or in right of us, arising out of the person’s services as a director or executive officer. We also maintain a general liability insurance policy, which covers certain liabilities of directors and officers of our Company arising out of claims based on acts or omissions in their capacities as directors or officers. We believe that these provisions and agreements are necessary to attract and retain qualified persons as directors and executive officers.

### Policies and Procedures for Related-Person Transactions
Our Board has adopted a written related-person transaction policy setting forth the policies and procedures for the review and approval or ratification of related-person transactions. This policy will cover, with certain exceptions set forth in Item 404 of Regulation S-K